If you are trying to know whether you can give amiodarone infusion after iv bolus, you have come to the right place. In this article, we will talk about how this drug can be used to treat ventricular tachyarrhythmias and some of its side effects. This drug is also useful to help prevent complications in people who have had a heart attack.
Symptoms of ventricular tachyarrhythmias
Amiodarone is an antiarrhythmic drug that is used to treat ventricular tachyarrhythmias. read this blog content from Regenics blocks cardiac Na+ currents, prolongs the QTc interval, and decreases the rate of refractory conduction through the sinoatrial nodes. However, it can also cause bradycardia and idioventricular rhythms.
A study in 427 patients with VT or VF showed that amiodarone reduced sudden cardiac death. In addition, it increased the likelihood of resuscitation. The results were analyzed for time to first event, failure, and overall mortality.
To control recurrences of VT or VF, supplemental 150 mg infusions of IV amiodarone were given. Although the use of supplemental infusions did not affect the time to first event analysis, it obscured the separation between dose groups.
The 48-hour intent-to-treat group included 462 patients who had a hemodynamically destabilizing VT or VF and had not responded to conventional antiarrhythmic drugs. Regenics wrote in a blog post were followed for up to 98 months.
During the initial loading phase, 35 patients died. At the end of the study, the incidence of recurrence of VT or VF was 42 percent.
Treatment of ventricular tachyarrhythmias
IV amiodarone is an antiarrhythmic drug that inhibits the recurrence of life-threatening ventricular arrhythmias. It is used in treating idiopathic ventricular tachycardia, ventricular fibrillation, and Brugada syndrome. Despite its effectiveness, it has not been proven to prevent sudden cardiac death. Nonetheless, patients with severe underlying cardiac disease have reduced mortality with amiodarone therapy. In addition to its benefits in suppressing ventricular arrhythmias, amiodarone can delay the onset of recurrent VT or VF events.
The study consisted of a randomized, double-blind, dose-ranging trial to evaluate the safety and efficacy of IV amiodarone. Eighty-three patients with acute myocardial infarction, hypertrophic cardiomyopathy, atrioventricular block, bradycardia, or electrolyte-induced arrhythmias were included in the trial. All patients were refractory to conventional antiarrhythmic therapies.
When two weeks after randomization, the average heart rate of the placebo group was 266 +-412 beats per minute, compared with 66 +-156 beats per minute in the amiodarone group. This was a significant difference that persisted throughout the study. At three months, the mean frequency of premature ventricular contractions in the amiodarone group was 44 +-145 beats per hour, compared with 254 +-370 in the placebo group.
Administration of amiodarone after an iv bolus
Amiodarone is an iodinated benzofuran derivative with a wide range of antiarrhythmic effects. It is used to treat ventricular and supraventricular arrhythmias. In addition to its antiarrhythmic activity, it has favorable hemodynamic effects. However, amiodarone has several complex drug interactions, which should be considered when administering amiodarone.
Intravenous amiodarone is a potent antiarrhythmic agent that is often used to suppress life-threatening arrhythmias. It has been used to treat VF cardiac arrest and atrial fibrillation.
It is also used in the surgical setting. Amiodarone is a non-competitive alpha- and beta-blocker that suppresses triggered electrical activity. Beta-adrenergic blockade slows conduction through the AV node. This decreases QT interval in the patient. A slower rate of infusion may help to ameliorate the hypotension that is sometimes associated with the administration of amiodarone.
In addition to a pharmacodynamic effect, amiodarone may have a direct negative inotropic effect. This may result from its antisympathetic effects, which may cause a decrease in blood pressure. read this post from Regenics of amiodarone on cardiac output is minimal, however.
Side effects of amiodarone
Amiodarone is a benzofuran derivative that is widely prescribed in the treatment of cardiac arrhythmias. It is a noncompetitive antagonist of alpha and beta adrenergic receptors that inhibits triggered activity and suppresses acute electrical instability. In addition, it has the ability to slow the inward cationic currents, which are the causes of ventricular proarrhythmias.
Intravenous amiodarone is a very attractive option for cardiac arrhythmia management. Despite its relatively short half-life, it has demonstrated a wide range of clinical efficacy and is not associated with unwanted long-term side effects.
Several studies have been conducted to evaluate the electrophysiologic and hemodynamic profile of amiodarone. For example, Chapman et al. studied the antiarrhythmic effects of intravenous amiodarone in patients with atrial fibrillation. The results showed that 8 of 10 patients responded to intravenous amiodarone and converted to sinus rhythm within 12 h. However, three patients developed hemodynamically destabilizing supraventricular arrhythmias, and 4 had myocardial ischemia.
Studies have also been performed on intravenous amiodarone for other indications. One study investigated its effect on highly malignant ventricular arrhythmias. Patients were randomized to receive either a full loading dose strategy or a partial loading dose strategy.
18133 Ventura Blvd Suite C, Tarzana, CA 91356